WHO ICTRP trial
Comparison of Helicobacter pylori Eradication plus Rebamipide combination…
JPRN-UMIN000003181 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000003181 |
|---|---|
| Public title | Comparison of Helicobacter pylori Eradication plus Rebamipide combination therapy with proton pump inhibitor(PPI) alone in the treatment of endoscopic submucosal dissection(ESD) induced ulcers in H.pylori positive eary gastric cancer: Prospective Randomized Pilot Syudy |
| Scientific title | Comparison of Helicobacter pylori Eradication plus Rebamipide combination therapy with proton pump inhibitor(PPI) alone in the treatment of endoscopic submucosal dissection(ESD) induced ulcers in H.pylori positive eary gastric cancer: Prospective Randomized Pilot Syudy - Helicobacter pylori… |
| Primary sponsor | Osaka Medical College |
| Secondary sponsors | Osaka City University Osaka Medical Center for Cancer and Cardiovascular Diseases Kyoto Prefectural University of Medicine Kobe University Nara Medical University Wakayama Medical University etc. |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | H.pylori positive eary gastric cancer |
| Interventions | Patients in the treatment group receive H.pylori eradication therapy(Omeprazole 40 mg/day, clarithromycin 800 mg/day, amoxicillin 1500 mg/day) for 7 days and then rebamipide (300 mg/day) for 7 weeks. Patients in the control group do not… |
| Registration date | Feb 14, 2010 |
| Target size | 120 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: